Publications by authors named "Tomoko Iwasaki"

Article Synopsis
  • Esaxerenone's effectiveness and safety were evaluated in patients with uncontrolled hypertension and left ventricular hypertrophy, primarily focusing on its impact while they were also taking other medications.
  • The 24-week study involved 60 patients, revealing significant decreases in morning and bedtime blood pressure and left ventricular mass index, along with mild adverse events.
  • Results suggest that esaxerenone is both effective in lowering blood pressure and safe for hypertensive patients with cardiac issues, indicating its potential as a beneficial treatment option.
View Article and Find Full Text PDF

A 93-year-old woman was transferred to our hospital for lightheadedness. She had had Takotsubo cardiomyopathy for seven years. Transthoracic apical four-chamber echocardiography showed a large apical aneurysm.

View Article and Find Full Text PDF
Article Synopsis
  • A 55-year-old Japanese man had multiple ulcers on his left leg for a year, linked to long-standing varicose veins.
  • Imaging revealed he lacked an inferior vena cava, resulting in enlarged surrounding veins.
  • Conservative treatments healed the ulcers in a month, showing a rare but notable connection between the absent vein and chronic leg ulcers.
View Article and Find Full Text PDF

We reported two patients with refractory eosinophilic fasciitis (EF) and provided a systematic review of the literature to determine the clinical variables associated with prognosis of EF. We enrolled 88 cases, whose clinical characteristics were analyzed by separating the patients into two or three groups based on outcome. The incidence of certain clinical and pathological features differed among the groups.

View Article and Find Full Text PDF

Carcinoembryonic antigen (CEA), an oncofetal glycoprotein overexpressed in most gastrointestinal and lung cancers, is a candidate molecule for cancer immunotherapy. Recently, a CEA-derived 9-mer peptide, CEA652 (TYACFVSNL), has been identified as the epitope of cytotoxic T lymphocytes restricted with human leukocyte antigen (HLA)-A24, which is present in 60% of the Japanese population and in some Caucasians. The authors performed a clinical study of a vaccine using autologous dendritic cells (DCs) pulsed with CEA652 and adjuvant cytokines, natural human interferon alpha (nhuIFN-alpha), and natural human tumor necrosis factor alpha (nhuTNF-alpha), for the treatment of patients with CEA-expressing advanced metastatic malignancies.

View Article and Find Full Text PDF